About the Journal

Pharmacology sits at the foundation of rational drug therapy — where molecular understanding becomes clinical application, where adverse drug reactions reveal drug interactions, and where pharmacokinetic principles guide dosing decisions. Kmed Journal of Pharmacology exists for the pharmacologists, clinical researchers, and pharmaceutical scientists who translate drug science into therapeutic benefit.

We publish original research, preclinical studies, clinical pharmacology trials, drug safety reports, and systematic reviews across the full breadth of pharmacological science. Whether you are reporting the mechanism of action of a novel compound, documenting adverse drug reactions from pharmacovigilance data, or evaluating comparative drug efficacy — if it advances how drugs are discovered, tested, or used safely, it belongs here. Every submission undergoes rigorous peer review, and every published article is freely accessible to the global pharmacology community.

Scope & Focus Areas

We welcome submissions across all dimensions of pharmacological science, including:

• Drug Discovery & Development — target identification, lead optimization, structure-activity relationships, and preclinical evaluation
• Clinical Pharmacology — pharmacokinetics, pharmacodynamics, drug-drug interactions, and dose optimization
• Pharmacovigilance & Drug Safety — adverse drug reactions, medication errors, post-marketing surveillance, and risk assessment
• Toxicology — drug toxicity, organ-specific toxicity, toxicokinetics, and safety pharmacology
• Neuropharmacology — CNS drugs, antidepressants, antiepileptics, analgesics, and neuroprotective agents
• Cardiovascular Pharmacology — antihypertensives, anticoagulants, lipid-lowering drugs, and cardiac therapeutics
• Antimicrobial Pharmacology — antibiotics, antifungals, antivirals, and resistance mechanisms
• Cancer Pharmacology — chemotherapy, targeted therapy, immunotherapy, and drug resistance
• Endocrine Pharmacology — diabetes medications, thyroid drugs, hormonal therapies, and metabolic regulators
• Immunopharmacology — immunosuppressants, immunomodulators, biologics, and vaccine adjuvants
• Herbal & Natural Product Pharmacology — phytochemistry, traditional medicine validation, and plant-derived therapeutics
• Pharmacogenomics — genetic determinants of drug response, personalized medicine, and precision dosing
• Regulatory & Translational Pharmacology — drug approval processes, bioequivalence, and bench-to-bedside translation

Why Publish With Us

Open Access Your research reaches every pharmacologist, drug researcher, and clinician — without paywalls. Published articles are freely accessible worldwide from the date of publication.

Peer Review You Can Trust Every manuscript is reviewed by subject-matter experts in pharmacology, toxicology, and pharmaceutical sciences. We prioritize methodological rigor, reproducibility, and translational relevance.

Fast Turnaround Initial editorial decision within 21 days. We respect your research timeline and understand the competitive nature of drug discovery research.

Author-Centered Process Dedicated editorial support from submission through publication — with guidance on dose-response curve presentation, pharmacokinetic parameter reporting, and preclinical study design.

Indexed & Discoverable Published articles are optimized for discoverability, ensuring your drug studies and pharmacological findings reach the researchers, clinicians, and pharmaceutical developers who can apply them.

Who Should Submit

Kmed Journal of Pharmacology is the right home for your work if you are a:

• MD Pharmacology resident or PhD scholar with experimental pharmacology research, clinical drug trials, or toxicology studies
• Pharmacologist or pharmaceutical scientist working on drug discovery, mechanism of action studies, or preclinical development
• Clinical pharmacologist with pharmacovigilance data, drug interaction studies, or therapeutic drug monitoring outcomes
• Faculty member or HOD in a Pharmacology department looking to build departmental research output and visibility
• Toxicologist, medicinal chemist, or pharmaceutical industry researcher working on drug development or safety evaluation

If your work advances how drugs are discovered, how they act at molecular and clinical levels, or how they can be used more safely — this journal is for you.

Article Types Accepted

Type	Description
Original Research	Experimental or clinical studies with primary pharmacological data
Preclinical Studies	Animal models, in vitro assays, mechanism of action, and drug screening
Clinical Pharmacology Trials	Pharmacokinetic/pharmacodynamic studies, dose-response evaluations, and bioavailability assessments
Drug Safety Reports	Adverse drug reactions, pharmacovigilance case series, and toxicity profiles
Review Articles	Systematic, narrative, or scoping reviews of pharmacological evidence
Method Development	Novel assay development, analytical techniques, and experimental protocols
Short Communications	Preliminary findings, novel drug targets, or brief pharmacological insights
Letters to the Editor	Responses, perspectives, or brief pharmacological commentaries

Submit Your Work

Every drug mechanism you elucidated, every adverse reaction you documented, every dose-response relationship you characterized — that pharmacological knowledge has value far beyond your laboratory bench or clinical trial. Published, it becomes a resource for every pharmacology researcher designing the next study, every clinician prescribing complex regimens, and every pharmaceutical developer translating preclinical findings into human therapeutics.

Submit a Manuscript → View Author Guidelines → Contact the Editorial Team →